The nonclassical major histocompatibility complex (MHC) class I molecule HLA-E inhibits natural killer (NK) cell–mediated lysis by interacting with CD94/NKG2A receptors. Surface expression of HLA-E depends on binding of conserved peptides derived from MHC class I molecules. The same peptide is present in the leader sequence of the human cytomegalovirus (HCMV) glycoprotein UL40 (gpUL40). It is shown that, independently of the transporter associated with antigen processing, gpUL40 can up-regulate expression of HLA-E, which protects targets from NK cell lysis. While classical MHC class I molecules are down-regulated, HLA-E is up-regulated by HCMV. Induction of HLA-E surface expression by gpUL40 may represent an escape route for HCMV. <br/
Human cytomegalovirus (HCMV) is a paradigm of pathogen immune evasion, and sustains lifelong persist...
Human histocompatibility leukocyte antigen (HLA)-E is a nonclassical major histocompatibility comple...
Human cytomegalovirus (HCMV) exploits a range of strategies to evade and modulate the immune respons...
The nonclassical major histocompatibility complex (MHC) class I molecule HLA-E inhibits natural kill...
The nonclassical major histocompatibility complex (MHC) class I molecule HLA-E inhibits natural kill...
The nonclassical major histocompatibility complex (MHC) class I molecule HLA-E inhibits natural kill...
Cytotoxic T cells are major players in the immune defence against human cytomegalovirus (HCMV). The ...
Human CMV (HCMV)-encoded NK cell-evasion functions include an MHC class I homolog (UL18) with high a...
Human cytomegalovirus (HCMV) is a well-studied b-her-pesvirus virus, which adopts a variety of strat...
HLA-E (human leucocyte antigen-E) is a conserved class I major histocompatibility molecule which has...
The protein HLA-E is a non-classical major histocompatibility complex (MHC) molecule of limited sequ...
Human histocompatibility leukocyte antigen (HLA)-E is a nonclassical HLA class I molecule, the gene ...
Human cytomegalovirus (HCMV) causes lifelong, persistent infections and its survival is under intens...
Natural killer (NK) cell recognition of the nonclassical human leukocyte antigen (HLA) molecule HLA-...
The major histocompatibility (MHC) class Ib molecules HLA-E, HLA-F and HLA-G are relatively non-poly...
Human cytomegalovirus (HCMV) is a paradigm of pathogen immune evasion, and sustains lifelong persist...
Human histocompatibility leukocyte antigen (HLA)-E is a nonclassical major histocompatibility comple...
Human cytomegalovirus (HCMV) exploits a range of strategies to evade and modulate the immune respons...
The nonclassical major histocompatibility complex (MHC) class I molecule HLA-E inhibits natural kill...
The nonclassical major histocompatibility complex (MHC) class I molecule HLA-E inhibits natural kill...
The nonclassical major histocompatibility complex (MHC) class I molecule HLA-E inhibits natural kill...
Cytotoxic T cells are major players in the immune defence against human cytomegalovirus (HCMV). The ...
Human CMV (HCMV)-encoded NK cell-evasion functions include an MHC class I homolog (UL18) with high a...
Human cytomegalovirus (HCMV) is a well-studied b-her-pesvirus virus, which adopts a variety of strat...
HLA-E (human leucocyte antigen-E) is a conserved class I major histocompatibility molecule which has...
The protein HLA-E is a non-classical major histocompatibility complex (MHC) molecule of limited sequ...
Human histocompatibility leukocyte antigen (HLA)-E is a nonclassical HLA class I molecule, the gene ...
Human cytomegalovirus (HCMV) causes lifelong, persistent infections and its survival is under intens...
Natural killer (NK) cell recognition of the nonclassical human leukocyte antigen (HLA) molecule HLA-...
The major histocompatibility (MHC) class Ib molecules HLA-E, HLA-F and HLA-G are relatively non-poly...
Human cytomegalovirus (HCMV) is a paradigm of pathogen immune evasion, and sustains lifelong persist...
Human histocompatibility leukocyte antigen (HLA)-E is a nonclassical major histocompatibility comple...
Human cytomegalovirus (HCMV) exploits a range of strategies to evade and modulate the immune respons...